Jennifer Sy - 17 May 2024 Form 3 Insider Report for AEON Biopharma, Inc. (AEON)

Role
PRINCIPAL ACCOUNTING OFFICER
Signature
/s/ Alexander Wilson as attorney-in-fact for Jennifer Sy
Issuer symbol
AEON
Transactions as of
17 May 2024
Net transactions value
$0
Form type
3
Filing time
24 May 2024, 20:02:41 UTC
Next filing
04 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AEON Stock Option 17 May 2024 Common Stock 96,349 $5.47 Direct F1
holding AEON Stock Option 17 May 2024 Common Stock 8,130 $14.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of stock options granted on August 14, 2023 (the "Grant Date"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
F2 Represents an award of stock options granted on March 19, 2024 (the "Grant Date"), which vests in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney